European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law. The essays are grouped under four themes: free movement of goods and persons, competition and intellectual
property; European drug regulation; biotechnology; and product liability and
transnational health care litigation. This important study offers a valuable resource for the pharmaceutical and
biotechnology industries, as well as legal academics and practitioners.
